Pro-inflammatory cytokines, including interleukin (IL)-1β, IL-2, IL-6, and tumor necrosis factor (TNF)-α, play an important role in the response of antidepressant-resistant patients to the drugs; the concentrations of these cytokines were significantly higher in these patients compared with patients without depression [5,6]. This evidence concerns the gene IL6 and depressive symptom measurement.